Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity

Trends in Pharmacological Sciences
Dennis K LeeBrian F O'Dowd

Abstract

The apelin receptor was initially classed as an orphan G-protein-coupled receptor, and little was known about its physiological functions until apelin, the endogenous ligand, was identified. Similarities between the structure and anatomical distribution of apelin and its receptor and that of angiotensin II and the angiotensin AT1 receptor provide clues about the physiological functions of this novel signal-transduction system. Now, roles have been established for the apelin system in lowering blood pressure, as a potent cardiac inotrope, in modulating pituitary hormone release and food and water intake, in stress activation, and as a novel adipokine that is excreted from fat cells and regulates insulin. Given its broad array of physiological roles, apelin has attracted much interest as a target for novel therapeutic research and drug design.

References

Dec 1, 1986·Hypertension·D T PalsG A Johnson
Oct 30, 1998·Biochemical and Biophysical Research Communications·K TatemotoM Fujino
May 5, 2001·Biochimica Et Biophysica Acta·Y KawamataM Fujino
May 22, 2001·Journal of Neurochemistry·A ReauxC Llorens-Cortès
Jan 10, 2002·Biochemical and Biophysical Research Communications·Bernard MasriYves Audigier
Jan 30, 2002·The Journal of Biological Chemistry·Chad VickersPeter Tummino
Mar 9, 2002·Biochemical and Biophysical Research Communications·Shahrad TaheriStephen Bloom
Jul 13, 2002·Neuroscience Letters·G Cristina BrailoiuNae J Dun
Aug 2, 2002·Neuroscience·A ReauxC Llorens-Cortes
Sep 7, 2002·Circulation Research·István SzokodiHeikki Ruskoaho
Dec 5, 2002·Autonomic Neuroscience : Basic & Clinical·Maryam SeyedabadiPaul M Pilowsky
Jun 10, 2003·Nutritional Neuroscience·Marie O'SheaMargaret J Morris
Jun 12, 2003·European Journal of Pharmacology·Xing ChengCatherine C Y Pang
Aug 14, 2003·Biochemical and Biophysical Research Communications·Gábor FöldesMiklós Tóth
Sep 10, 2003·Circulation·Mary M ChenThomas Quertermous
Dec 4, 2003·Neuroscience Letters·David SunterSuzanne L Dickson
Dec 3, 2003·The Journal of Biological Chemistry·Dennis K LeeBrian F O'Dowd
Jul 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Nadia De MotaCatherine Llorens-Cortes
Sep 15, 2004·Circulation·Mark F BerryY Joseph Woo
Sep 24, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Bernard MasriYves Audigier
Nov 9, 2004·Biochemical and Biophysical Research Communications·Atsushi KasaiAkemichi Baba
Nov 16, 2004·Neuroscience·M JászberényiG Telegdy
Dec 8, 2004·Regulatory Peptides·Shuntaro KagiyamaMitsuo Iida
Dec 14, 2004·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·C AsensioF Rohner-Jeanrenaud
Dec 17, 2004·Cellular Signalling·B MasriY Audigier
Dec 29, 2004·Cardiovascular Research·Euan A AshleyThomas Quertermous
Jan 29, 2005·Endocrinology·Jérémie BoucherPhilippe Valet
May 24, 2005·Pharmacology & Therapeutics·Matthias J Kleinz, Anthony P Davenport
Jun 2, 2005·Regulatory Peptides·Etsuko SusakiGeorge H Greeley
Aug 18, 2005·Experimental Physiology·William G Haynes
Sep 1, 2005·The Journal of Laboratory and Clinical Medicine·Lilach O LermanClaudio Napoli

❮ Previous
Next ❯

Citations

Feb 15, 2008·Journal of the American Society of Nephrology : JASN·Michel AziziCatherine Llorens-Cortes
Sep 5, 2008·The Journal of Clinical Investigation·Hyung J ChunThomas Quertermous
May 23, 2009·International Journal of Biological Sciences·Stefanie SchilffarthBajram Berisha
Sep 22, 2009·American Journal of Physiology. Heart and Circulatory Physiology·David N CharoThomas Quertermous
Nov 20, 2009·BMC Research Notes·Svanhild NornesMichael Lardelli
Sep 18, 2010·Mediators of Inflammation·Zhaoxia Wang, Tomohiro Nakayama
Dec 5, 2008·Digestive Diseases and Sciences·Susan E WozniakEldo E Frezza
Oct 25, 2008·Blood·Richard P Phipps
Sep 3, 2010·Wiener medizinische Wochenschrift·Carmen GelsingerChristoph F Ebenbichler
Jun 12, 2009·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·John J ByrnesDominic Picarella
Nov 20, 2012·The Journal of Endocrinology·Harman S Mattu, Harpal S Randeva
Aug 15, 2013·The Journal of Endocrinology·Anne-Marie O'CarrollGeorge R Pope
Dec 17, 2010·Cardiovascular Drugs and Therapy·Wei-Wen HungShyi-Jang Shin
Oct 22, 2011·Peptides·Paulina PiairoJorge Correia-Pinto
Mar 6, 2016·Clinica Chimica Acta; International Journal of Clinical Chemistry·Shifang HuangLanfang Li
Dec 29, 2009·Regulatory Peptides·Malin GrönbergJan Saras
Aug 8, 2009·Regulatory Peptides·Guiyun WangGeorge H Greeley
Nov 21, 2007·Trends in Cardiovascular Medicine·Oreste GualilloFrancisca Lago
Feb 15, 2008·Biochemical Pharmacology·Alan G Japp, David E Newby
Nov 21, 2007·Regulatory Peptides·Matthias J Kleinz, Gary F Baxter
Aug 19, 2007·Regulatory Peptides·Jiu-Chang ZhongXi-Yong Yu
May 1, 2007·Biochemical and Biophysical Research Communications·Klára FarkasfalviCesare M N Terracciano
Nov 30, 2006·Drug Discovery Today·S Caroline SorliYves Audigier
Jul 24, 2010·British Journal of Pharmacology·Sarah L PitkinAnthony P Davenport
Jul 14, 2011·Journal of Neurochemistry·Denise R CookDennis L Kolson
Feb 1, 2011·Annals of the New York Academy of Sciences·Yingfeng Deng, Philipp E Scherer
Jul 13, 2013·Hypertension in Pregnancy : Official Journal of the International Society for the Study of Hypertension in Pregnancy·Hiromi InuzukaYasuhiro Udagawa
Feb 1, 2014·Expert Opinion on Therapeutic Targets·Efthymia A Katsareli, George V Dedoussis
Mar 13, 2008·Structure·Alexander I AlexandrovRaymond C Stevens
Mar 29, 2011·Journal of Vascular Surgery·Daynene Vykoukal, Mark G Davies
Mar 17, 2009·Circulation Research·Matthew R Swift, Brant M Weinstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.